Odicef 750mg Injection
Manufacturer
Galpha Laboratories Ltd
Salt Composition
Ceftriaxone (750mg)
Key Information
Short Description
Odicef 750mg Injection is an antibiotic used to treat bacterial infections in the body, effective in infections of the brain, lungs, ear, urinary tract, skin, bones, joints, blood, and heart.
Dosage Form
Injection
Introduction
Odicef 750mg Injection is an antibiotic belonging to the cephalosporin group, used to treat bacterial infections in your body. It is effective in infections of the brain, lungs, ear, urinary tract, skin & soft tissues, bones & joints, blood, and heart.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Safety Information
Side Effects
Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.
Alcohol Warning
Consuming alcohol with Odicef 750mg Injection does not cause any harmful side effects.
Breastfeeding Warning
Odicef 750mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnancy Warning
Odicef 750mg Injection is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
How it works
Odicef 750mg Injection is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive.
Quick Tips
Your doctor has prescribed Odicef 750mg Injection to cure your infection and improve your symptoms. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat. Discontinue Odicef 750mg Injection and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing. Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.
Frequently asked questions
Is Odicef 750mg Injection safe?
Odicef 750mg Injection is a safe medication when taken exactly as prescribed by your healthcare professional. Follow all instructions given and report any unusual side effects to your doctor.
How long does Odicef 750mg Injection take to work?
Odicef 750mg Injection usually starts working soon after administration. It may take several days for the medication to completely eliminate harmful bacteria and relieve your symptoms.
Who should not take Odicef 750mg Injection?
Odicef 750mg Injection is not recommended for individuals with known allergies to any ingredient in the medication. You must disclose any pre-existing liver, kidney, gallbladder, or blood-related disorders such as hemolytic anemia to your healthcare provider. If you are pregnant, breastfeeding, or planning a pregnancy, please consult your doctor before using Odicef 750mg Injection.
What if I do not get better after using Odicef 750mg Injection?
It is crucial to inform your healthcare provider if you experience no improvement or worsening of symptoms after completing the full course of treatment. Be sure to report any significant changes in your condition.
For how long does Odicef 750mg Injection stay in the body?
Odicef 750mg Injection usually remains in the body for around two days after stopping the medication completely. This is a general guideline, and specific information may vary based on individual factors.
Is Odicef 750mg Injection effective?
The effectiveness of Odicef 750mg Injection depends on proper usage as prescribed by your healthcare professional. Do not stop taking the medication prematurely, and ensure you adhere to all instructions for optimal results.
How is Odicef 750mg Injection administered?
Odicef 750mg Injection should only be administered under the guidance of a qualified healthcare professional or your doctor. The dosage will be determined by your individual condition and prescribed accordingly.
